---
book: Congenital Disorders
title: Clinical features, diagnosis, treatment, genetic counselling and prevention of common congential disorders
layout: chapter
---

# Addendum A: Clinical features, diagnosis, treatment, genetic counselling and prevention of common congential disorders

<table style="width: 100%;">
<thead>
  <tr>
    <td colspan="2"><p>Single gene defects</p></td>
  </tr>
  </thead>
  <tbody>
  <tr class="table-subhead">
    <td colspan="2"><p>Common Autosomal Recessive Disorders</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Oculocutaneous albinism</p>
      <p>(Autosomal recessive – 1 in 5000 in sub Saharan Africa)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Skin, hair and retina lack of pigmented</p>
      <p>Skin and eye hypersensitivity to sunlight</p>
      <p>Increased risk of skin cancer</p>
      <p>Reduced visual acuity and nystagmus</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>DNA diagnosis available**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Treat skin infections*</p>
      <p>Sunscreen*</p>
      <p>Surgery for skin cancer</p>
      <p>Glasses for reduced vision</p>
      <p>Genetic counselling*</p>
      <p>Advice on skin and eye care and coverage with clothes and wide brimmed hats*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family planning, family history* and preconception DNA carrier screening**</p>
      <p>2° – Prenatal carrier screening and prenatal DNA diagnosis**</p>
      <p>3° – Early detection* and treatment of skin cancer</p></td>
  </tr>
  <tr class="table-subhead">
    <td colspan="2"><p>Common Autosomal Recessive Disorders</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Cystic fibrosis</p>
      <p>(Autosomal recessive – 1 in 2000 European and 1 in 2500 in Middle Eastern countries)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Recurrent chest infections and wheeze</p>
      <p>Clubbing of fingers</p>
      <p>Chronic diarrhoea</p>
      <p>Malabsorption</p>
      <p>Failure to thrive</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Sweat test**</p>
      <p>DNA diagnosis**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Aggressive treatment of respiratory infections (antibiotics, bronchodilators, physiotherapy)</p>
      <p>Pancreatic enzyme replacement</p>
      <p>Gene therapy in the future</p>
      <p>Genetic counseling**</p>
      <p>Prevention:</p>
      <p>1° – Family planning, family history* and preconception carrier screening**</p>
      <p>2° – Prenatal carrier screening and prenatal diagnosis**</p>
      <p>3° – Newborn screen</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Sickle cell anaemia</p>
      <p>(Autosomal recessive. Birth prevalence varies in different countries – 1 in 50 newborns in Nigeria)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Moderate to severe haemolytic anaemia</p>
      <p>Haemolytic or aplastic crises</p>
      <p>Jaundice</p>
      <p>Initially splenomegaly but later this disappears</p>
      <p>Hyposplenism</p>
      <p>Increased susceptibility to infection (especially Streptococcus pneumoniae, Haemophilus influenzae, Salmonella, malaria)</p>
      <p>Vaso-occlusive episodes (abdominal including kidneys and spleen, dactylitis, priapism, stroke)</p>
      <p>Leg ulcers, aseptic necrosis of bone</p>
      <p>Cholelithiasis (gallstones)</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Full Blood Count-normocytic/mildly macrocytic anaemia, reticulocytosis, target cells</p>
      <p>Haemoglobin electrophoresis-increased haemoglobin F and S</p>
      <p>Positive sickling test</p>
      <p>Increased serum bilirubin</p>
      <p>DNA diagnosis**</p>
      <p>X-rays - increased medullary spaces and cortical thinning, avascular necrosis of bone</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Prevention or early treatment of infections (vaccines, antibiotics, anti-malarials)*</p>
      <p>Maintain hydration to prevent crises</p>
      <p>Manage crises and acute complications</p>
      <p>Genetic counselling*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family planning, family history* and preconception population carrier screening**</p>
      <p>2° – Prenatal carrier screening and prenatal diagnosis**</p>
      <p>3° – Newborn screening</p></td>
  </tr>
  <tr class="table-subhead">
    <td colspan="2"><p>Rarer Single Gene Defects</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Neurofibromatosis I</p>
      <p>(Autosomal dominant – 1 in 3000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Café-au-lait patches</p>
      <p>Neurofibroma</p>
      <p>Axillary freckling</p>
      <p>Macrocephaly (head circumference above 97th centile)</p>
      <p>Scoliosis</p>
      <p>Learning difficulties</p>
      <p>Complication from compression by neurofibroma</p>
      <p>Increased risk of malignancy in neurofibroma</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>DNA diagnosis available</p>
      <p>Neurodevelopmental/psychometric assessment</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Surgery when indicated and if available</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Tuberous sclerosis</p>
      <p>(Autosomal dominant – 1 in 15 000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Variable expressivity</p>
      <p>Adenoma sebaceum and café-au-lait patches</p>
      <p>Ash leaf patches and shagreen patches</p>
      <p>CNS (cortical) tubers on CT scan</p>
      <p>Renal angiomyolipoma</p>
      <p>Ungual fibroma</p>
      <p>Intellectual disability and epilepsy</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>DNA diagnosis available</p>
      <p>Neurodevelopmental/psychometric assessment</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Surgery if indicated</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Seizure control</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Huntington disease</p>
      <p>(Autosomal dominant – 1 in 10 000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Adult onset (Average age 35 years)</p>
      <p>Progressive involuntary movements (chorea)</p>
      <p>Progressive dementia and psychiatric symptoms</p>
      <p>Weight loss</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>DNA diagnosis*** Presymptomatic testing possible**</p>
      <p>Brain scan**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>No effective treatment. Diagnosis to death averages 15 years</p>
      <p>Psychosocial support</p>
      <p>Genetic counselling</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family history*, presymptomatic and pre-pregnancy (DNA) diagnosis** and family planning*</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)**</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Achondroplasia</p>
      <p>(Autosomal dominant 1 in 26 000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Skeletal dysplasia with asymmetric short stature (short limbs)</p>
      <p>Macrocephaly (head circumference above 97th centile)</p>
      <p>Trident hand. May develop hydrocephalus and spinal cord compression</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>DNA diagnosis available</p></td>
    <td><p>Treatment and Counselling</p>
      <p>Surgery when indicated and if available</p>
      <p>Avoid contact sports</p>
      <p>Genetic counseling</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>Genetic counselling**</p>
      <p>2° – Prenatal diagnosis (ultrasound** /DNA diagnosis)</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Myotonic dystrophy</p>
      <p>(Autosomal dominant 1 in 9000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Presents usually in young adults. Progressive muscular weakness</p>
      <p>Myotonia and frontal baldness</p>
      <p>Cataracts</p>
      <p>Cardiac conduction defects</p>
      <p>Hypogonadism</p>
      <p>Congenital form (gene inherited from mother) severe hypotonia, facial diplegia, ptosis, arthrogryposis,cataracts</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Electromyography (EMG)**</p>
      <p>DNA diagnosis**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Supportive</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family history* and DNA diagnosis**</p>
      <p>Family planning*</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)**</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Waardenburg syndrome</p>
      <p>(Autosomal dominant – 1 in 30 000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Sensorineural deafness</p>
      <p>Poliosis (White forelock/early greying)</p>
      <p>Sapphire blue eyes or eyes of different colours (heterochromia)</p>
      <p>Partial albinism</p>
      <p>Telecanthus and medial eyebrow flare</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>Audiology**</p>
      <p>DNA diagnosis**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Hearing aid</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>Nil</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Congenital hypothyroidism</p>
      <p>(Autosomal recessive 1 in 4000)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Feeding problems</p>
      <p>Decreased activity</p>
      <p>Constipation</p>
      <p>Macroglossia (Large tongue)</p>
      <p>Hypothermia and dry skin</p>
      <p>Umbilical hernia</p>
      <p>Intellectual disability/deafness</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Thyroid function tests – Thyroid stimulating hormone (TSH)</p>
      <p>Free thyroxine (T3 and T4)**</p>
      <p>Neurodevelopmental/psychometric assessment**</p>
      <p>Audiological testing (Pendred syndrome – have deafness)**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Growth monitoring*</p>
      <p>Thyroxine</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>3° – Newborn screening (Not presently done universally in South Africa)</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Fragile X syndrome</p>
      <p>(X-linked recessive 1 in 2000 males)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Intellectual disability</p>
      <p>Speech disability</p>
      <p>Autistic-like behaviour</p>
      <p>Macrocephaly</p>
      <p>Long narrow faces with large ears</p>
      <p>Testicular enlargement</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>DNA diagnosis**</p>
      <p>Neurodevelopmental/psychometric assessment**</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family history* and carrier screening**</p>
      <p>Family planning*</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)**</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Haemophilia A and B</p>
      <p>(X-linked recessive – Haemophilia A 1 in 2000 males/Haemophilia B 1 in 20 000 males)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Spontaneous bleeding disorder</p>
      <p>Variable clinical expression</p>
      <p>Haemarthrosis</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Prolonged partial thromboplastin time</p>
      <p>Decreased factor VIII (A) or IX (B) in blood**</p>
      <p>DNA diagnosis available**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Replace factor VIII (A) or IX (B)*</p>
      <p>Pain relief*</p>
      <p>Splinting*</p>
      <p>Physiotherapy/CBR*</p>
      <p>Genetic counselling*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family history* and DNA carrier screening**</p>
      <p>Family planning*</p>
      <p>2° – Prenatal diagnosis (DNA diagnosis)**</p>
      <p>3° – Avoid injury</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Duchenne Muscular Dystrophy</p>
      <p>(X-linked recessive 1 in 3700 males)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Clinical onset 3–5 years of age</p>
      <p>Gait abnormalities</p>
      <p>Weakness of the pelvic girdle</p>
      <p>Gower sign</p>
      <p>Pseudohypertrophy of the calves</p>
      <p>Tightening of the Achilles tendons</p>
      <p>Lumbar lordosis</p>
      <p>Progressive muscle weakness and atrophy of muscles</p>
      <p>Loss of ability to walk by 9-16 years</p>
      <p>Cardiomyopathy/heart failure</p>
      <p>Respiratory failure</p>
      <p>Death by 25 years</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>High creatine phosphokinase (CPK)</p>
      <p>DNA diagnosis**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Physiotherapy</p>
      <p>Surgery if indicated**</p>
      <p>Cardiac failure treatment*</p>
      <p>Treatment of respiratory infection*</p>
      <p>Wheel chair</p>
      <p>Genetic counselling**</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family history* and DNA carrier screening**</p>
      <p>Family planning* and 2° – prenatal diagnosis (DNA diagnosis)**</p></td>
  </tr>
  </tbody>
</table>

<table style="width: 100%;">
<thead>
  <tr>
    <td colspan="2"><p>Chromosomal disorders</p></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><p>Down syndrome</p>
      <p>Currently 1 in 500 live births in South Africa</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Hypotonia</p>
      <p>Intellectual disability</p>
      <p>Craniofacial: brachycephaly, flat face, up-slanting palpebral fissures, epicanthic folds, flat nasal bridge, small, low set ears, squint, relative macroglossia, Brushfield spots (Caucasians)</p>
      <p>Short stature</p>
      <p>Brachydactyly, single palmar creases, 5th finger clinodactyly and hypoplasia mid-phalanx</p>
      <p>Sandal gap between first and second toes, plantar creases</p>
      <p>Small penis/hypogonadism</p>
      <p>Congenital heart disease</p>
      <p>Duodenal atresia</p>
      <p>Recurrent infection, especially of the respiratory tract</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Chromosomal/ FISH analysis/QR-PCR**</p>
      <p>Trisomy 21 – 95%</p>
      <p>Mosaicism – 2.5%</p>
      <p>Translocation – 2.5%</p>
      <p>Thyroid function tests</p>
      <p>Neurodevelopmental/psychometric assessment</p>
      <p>Cardiac assessment</p>
      <p>Audiology</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Growth monitoring</p>
      <p>Surgery when indicated and available</p>
      <p>Treatment for cardiac failure*</p>
      <p>Treatment of infections*</p>
      <p>Thyroxine if indicated</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Genetic counselling*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family planning and preconception care*</p>
      <p>2° – Prenatal (AMA) screening* Ultrasound and maternal serum screening for Down syndrome</p>
      <p>Prenatal chromosome/QR-PCR diagnosis**</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Trisomy 18</p>
      <p>(1 in 1500 live births)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Decreased fetal movement. Prenatal growth deficiency</p>
      <p>Severe developmental delay</p>
      <p>Hypertonia with weak cry, poor sucking</p>
      <p>Craniofacial: bifrontal narrowing, prominent occiput, microcephaly, low set malformed ears, short palpebral fissures, small chin and mouth, cleft lip/palate</p>
      <p>Clenched hands, overriding fingers</p>
      <p>Rocker-bottom feet, clubfeet</p>
      <p>Congenital heart disease</p>
      <p>Genital hypoplasia</p>
      <p>Neonatal or early infant death</p>
      <p>Diagnosis:</p>
      <p>Chromosomal/ FISH analysis/QR-PCR**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Supportive/ Palliative care*</p>
      <p>Genetic counselling*</p>
      <p>Supportive</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p><br />
      </p>
      <p>1° – Family planning and preconception care*</p>
      <p>2° – Prenatal screening for chromosomal disorders</p>
      <p>Ultrasound scanning for congential disorders.</p>
      <p>Prenatal diagnosis. Chromosomal/ FISH analysis/QR-PCR.**</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Trisomy 13</p>
      <p>(1 in 4500 live births)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Prenatal growth deficiency</p>
      <p>CNS malformations</p>
      <p>Hypertonia/hypotonia with severe developmental delay</p>
      <p>Craniofacial: Microcephaly/ sloping forehead, microphthalmia, anophthalmia, abnormal ears, cleft lip/palate, micrognathia</p>
      <p>Polydactyly, camptodactyly, convex hypoplastic finger nails, cryptorchidism</p>
      <p>Congenital heart disease</p>
      <p>Neonatal or early infant death</p>
      <p>Diagnosis:</p>
      <p>Chromosomal/ FISH analysis/QR-PCR.**</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Supportive/ Palliative care*</p>
      <p>Genetic counselling*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Family planning and preconception care*</p>
      <p>2° – Prenatal screening for chromosomal disorders</p>
      <p>Ultrasound scanning for congential disorders</p>
      <p>Prenatal chromosome diagnosis**</p>
      <p><br />
      </p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Turner syndrome</p>
      <p>(1 in 1000 female live births)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Female phenotype</p>
      <p>Short stature</p>
      <p>Congenital heart disease (aortic stenosis/ coarctation of aorta)</p>
      <p>Renal anomalies</p>
      <p>Ovarian dysgenesis/infertility</p>
      <p>Learning difficulties</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Chromosomal/ FISH analysis/QF-PCR**</p>
      <p>Monosomy XO/ Turner mosaics</p>
      <p>Neurodevelopmental/psychometric assessment</p>
      <p>Cardiac assessment</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Growth monitoring*</p>
      <p>Surgery when indicated and if available**</p>
      <p>Ovarian hormone replacement therapy**</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Genetic counselling**</p>
      <p>Prevention:</p>
      <p>1° – Family planning and preconception care*</p>
      <p>2° – Prenatal screening for chromosomal disorders</p>
      <p>Ultrasound scanning for congential disorders</p>
      <p>Prenatal diagnosis. Chromosomal/ FISH analysis/QR-PCR**</p></td>
  </tr>
  </tbody>
</table>


<table style="width: 100%;">
<thead>
  <tr>
    <td colspan="2"><p>Multifactorial disorders</p></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><p>Spina bifida</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Spinal lesion with paraplegia/ incontinence</p>
      <p>Hydrocephalus and developmental delay</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis</p>
      <p>Brain ultrasound/ CAT scan</p>
      <p>Urological assessment</p>
      <p>Neurodevelopmental/psychometric assessment</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Surgery when indicated and if available</p>
      <p>Incontinence care</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support</p>
      <p>Palliative care*</p>
      <p>Prevention:</p>
      <p>Genetic counselling*</p>
      <p>1° – Optimising women’s diet. Folic acid supplementation*</p>
      <p>2° – Maternal serum alpha feto-protein screening</p>
      <p>Ultrasound scanning for congential disorders</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Anencephaly</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Incomplete development and closure of the skull and development of the brain.</p>
      <p>Incompatible with life.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Palliative care*</p>
      <p>Prevention:</p>
      <p>Genetic counselling.*</p>
      <p>1° – Optimising women’s diet. Folic acid supplementation.*</p>
      <p>2° – Maternal serum alpha feto-protein screening.</p>
      <p>Ultrasound scanning for congential disorders.</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Encephalocele</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Incomplete closure of the skull with out-pouching containing neural tissue.</p>
      <p>Microcephaly.</p>
      <p>Developmental delay.</p>
      <p>Seizures.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p>
      <p>Brain scan.</p>
      <p>Neurodevelopmental/psychometric assessment.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Surgery when indicated and if possible.</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</p>
      <p>Seizure control.</p>
      <p>Genetic counselling*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Optimising women’s diet. Folic acid supplementation.*</p>
      <p>2° – Ultrasound scanning for congential disorders.</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Cleft lip/palate</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Cleft lip and/or palate.</p>
      <p>Feeding problems.</p>
      <p>Speech difficulties.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p>
      <p>Audiology.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Surgery.</p>
      <p>Feeding plate in infancy.</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</p>
      <p>Genetic counselling.*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>Nil.</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Talipes equinovarus</p>
      <p>(Clubfoot)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Fixed equinovarus deformation of the foot (feet).</p>
      <p>X-rays.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Manipulation and plaster of Paris casts.</p>
      <p>Surgery when indicated.</p>
      <p>Genetic counselling.*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>Nil.</p></td>
  </tr>
  </tbody>
  </table>
  
  
<table style="width: 100%;">
  <thead>
  <tr>
    <td colspan="2"><p>Teratogens</p></td>
  </tr>
  </thead>
  <tbody>
  <tr>
    <td colspan="2"><p>Fetal alcohol syndrome</p>
      <p>(Prevalence varies between communities. Estimated more than 1% of South African infants are born with FAS)</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Pre- and post natal growth deficiency.</p>
      <p>Microcephaly.</p>
      <p>Intellectual disability.</p>
      <p>Behaviour disorder.</p>
      <p>Craniofacial: short palpebral fissures, short upturned nose, smooth philtrum, thin vermillion border.</p>
      <p>Joint anomalies.</p>
      <p>Congenital heart defects.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Neurodevelopmental/psychometric assessment.</p>
      <p>Cardiac assessment.</p>
      <p>Growth monitoring.*</p>
      <p>Surgery when indicated and if available.</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</p>
      <p>Neuro-behavioural management.</p>
      <p>Genetic counseling.*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Optimising women’s diet.</p>
      <p>Public education on the bad effects of alcohol use and abuse in pregnancy.*</p></td>
  </tr>
  <tr>
    <td colspan="2"><p>Fetal rubella syndrome</p></td>
  </tr>
  <tr>
    <td><p>Clinical features:</p>
      <p>Growth deficiency.</p>
      <p>Microcephaly.</p>
      <p>Intellectual disability.</p>
      <p>Sensori-neural deafness.</p>
      <p>Cataracts, chorioretinitis, microphthalmia, squint.</p>
      <p>Congenital heart disease (PDA, septal defects, peripheral pulmonary stenosis).</p>
      <p>Hepatosplenomegaly.</p>
      <p>Thrombocytopenia, anaemia.</p>
      <p><br />
      </p>
      <p>Diagnosis:</p>
      <p>Clinical diagnosis.</p>
      <p>Serum IgG and IgM for rubella. Identify virus in urine.</p>
      <p>Neurodevelopmental/psychometric assessment.</p>
      <p>Visual assessment.</p>
      <p>Audiology.</p>
      <p>Cardiac assessment.</p>
      <p>Full Blood Count.</p></td>
    <td><p>Treatment and Counselling:</p>
      <p>Growth monitoring.*</p>
      <p>Surgery when indicated and if available.</p>
      <p>Auditory and vision management.</p>
      <p>Neurodevelopmental therapy/ community based rehabilitation including psychosocial support.</p>
      <p>Genetic counselling.*</p>
      <p><br />
      </p>
      <p>Prevention:</p>
      <p>1° – Preventing maternal infection by mass rubella immunisation.</p>
      <p>2° – Prenatal screening for sero-negativity and immunisation prior to subsequent pregnancy.*</p>
      <p>Detection of congenital malformations with ultrasound screening.</p>
      <p>Avoid contact between pregnant women and ill children</p>
      <p><br />
      </p></td>
  </tr>
  </tbody>
</table>


Abbreviations:

\* Possible in primary health care.  
\*\* Available in South Africa  
1° – Primary prevention (Preconception and early postconception period).  
2° – Secondary prevention (Antenatal period).  
3° – Tertiary prevention (Postnatal period).  
CBR. Community-based rehabilitation  
FISH. Fluorescent in situ hybridisation  

(Adapted from Christianson A L and Modell B. *Medical Genetics in Developing Countries*, Ann. Rev. Genomics Hum Genetics. 2004;5: 219–265).
